Cholesteryl ester transfer protein: friend or foe?
作者信息
Fielding C J, Havel R J
出版信息
J Clin Invest. 1996 Jun 15;97(12):2687-8. doi: 10.1172/JCI118719.
Abstract
摘要
相似文献
1
Cholesteryl ester transfer protein: friend or foe?胆固醇酯转运蛋白：益友还是劲敌？
J Clin Invest. 1996 Jun 15;97(12):2687-8. doi: 10.1172/JCI118719.
2
Molecular mechanism of reverse cholesterol transport: reaction of pre-beta-migrating high-density lipoprotein with plasma lecithin/cholesterol acyltransferase.逆向胆固醇转运的分子机制：前β迁移高密度脂蛋白与血浆卵磷脂/胆固醇酰基转移酶的反应
Biochemistry. 2004 Nov 23;43(46):14811-20. doi: 10.1021/bi0485629.
3
Cholesteryl ester transfer protein inhibition: effect on reverse cholesterol transport?
Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):681-4. doi: 10.1161/01.ATV.0000214979.24518.95.
4
An overview of reverse cholesterol transport.逆向胆固醇转运概述。
Eur Heart J. 1998 Feb;19 Suppl A:A31-5.
5
Function of cholesteryl ester transfer protein in reverse cholesterol transport.胆固醇酯转运蛋白在胆固醇逆向转运中的作用。
CMAJ. 1993 Jun 15;148(12):2165-6.
6
Therapeutic implications of cholesteryl ester transfer protein inhibitors in hyperlipidemia and low high-density lipoprotein-cholesterolemia.胆固醇酯转运蛋白抑制剂在高脂血症和低高密度脂蛋白胆固醇血症中的治疗意义
Curr Opin Investig Drugs. 2003 Mar;4(3):291-7.
7
[Cholesterol ester transfer protein. A major player in cholesterol metabolism].[胆固醇酯转运蛋白。胆固醇代谢的主要参与者]
Ugeskr Laeger. 1999 Sep 20;161(38):5295-8.
8
Cholesteryl ester transfer protein directly mediates selective uptake of high density lipoprotein cholesteryl esters by the liver.胆固醇酯转运蛋白直接介导肝脏对高密度脂蛋白胆固醇酯的选择性摄取。
Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2177-84. doi: 10.1161/01.ATV.0000183613.13929.13. Epub 2005 Aug 25.
9
Lipoprotein profile and cholesteryl ester transfer protein in neonates.新生儿的脂蛋白谱与胆固醇酯转运蛋白
Metabolism. 2001 Jun;50(6):723-8. doi: 10.1053/meta.2001.23307.
10
Wiedendiol-A inhibits cholesteryl ester binding to its transfer protein.维登二醇 - A抑制胆固醇酯与其转运蛋白的结合。
Zhongguo Yao Li Xue Bao. 1998 Sep;19(5):408-12.
引用本文的文献
1
Effects of dietary interventions and intermittent fasting on HDL function in obese individuals with T2DM: a randomized controlled trial.膳食干预和间歇性禁食对 T2DM 肥胖个体 HDL 功能的影响：一项随机对照试验。
Cardiovasc Diabetol. 2024 Sep 12;23(1):339. doi: 10.1186/s12933-024-02426-5.
2
Residual risks and evolving atherosclerotic plaques.残留风险与不断演变的动脉粥样硬化斑块。
Mol Cell Biochem. 2023 Dec;478(12):2629-2643. doi: 10.1007/s11010-023-04689-0. Epub 2023 Mar 10.
3
Disease-associated marked hyperalphalipoproteinemia.疾病相关的显著高α脂蛋白血症。
Mol Genet Metab Rep. 2014 Jun 30;1:264-268. doi: 10.1016/j.ymgmr.2014.06.001. eCollection 2014.
4
Cholesteryl ester transfer protein: ace of spades, queen of hearts, or the joker?胆固醇酯转运蛋白：黑桃A、红桃皇后，还是百搭牌？
Front Pharmacol. 2015 Jul 14;6:145. doi: 10.3389/fphar.2015.00145. eCollection 2015.
5
Association of cholesteryl ester transfer protein genotypes with paraoxonase-1 activity, lipid profile and oxidative stress in type 2 diabetes mellitus: A study in San Luis, Argentina.胆固醇酯转运蛋白基因型与2型糖尿病患者对氧磷酶-1活性、血脂谱及氧化应激的关系：阿根廷圣路易斯的一项研究
J Diabetes Investig. 2015 Jan;6(1):67-77. doi: 10.1111/jdi.12256. Epub 2014 Jul 25.
6
Meta-analysis of cholesteryl ester transfer protein TaqIB polymorphism and risk of myocardial infarction.胆固醇酯转运蛋白TaqIB多态性与心肌梗死风险的Meta分析。
Medicine (Baltimore). 2014 Nov;93(26):e160. doi: 10.1097/MD.0000000000000160.
7
CETP inhibitors and cardiovascular disease: Time to think again.CETP抑制剂与心血管疾病：是时候重新思考了。
F1000Res. 2014 Jun 10;3:124. doi: 10.12688/f1000research.4396.1. eCollection 2014.
8
HDL-targeted therapies: progress, failures and future.靶向高密度脂蛋白的治疗策略：进展、失败与未来
Nat Rev Drug Discov. 2014 Jun;13(6):445-64. doi: 10.1038/nrd4279. Epub 2014 May 23.
9
Utilizing imaging tools in lipidology: examining the potential of MRI for monitoring cholesterol therapy.脂质学中成像工具的应用：探讨磁共振成像监测胆固醇治疗的潜力。
Clin Lipidol. 2012 Jun;7(3):329-343. doi: 10.2217/clp.12.33.
10
Association of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the community.循环胆固醇酯转移蛋白活性与社区人群心血管疾病发病的相关性。
Circulation. 2009 Dec 15;120(24):2414-20. doi: 10.1161/CIRCULATIONAHA.109.872705.
Zotero 插件